Sestrins: a new therapeutic target for endothelial dysfunction and cardiovascular disease prevention
Sestrins emerge as promising therapeutic targets for the prevention and treatment of endothelial dysfunction and cardiovascular diseases. This review underscores the potential of Sestrins in vascular biology and advocates for further research to elucidate their mechanisms and clinical applicability in cardiovascular medicine.
Authors
- Xu Zhang (ORCID: https://orcid.org/0009-0002-2798-8920)
- Cheng Li (ORCID: https://orcid.org/0000-0003-2439-1627)
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
- Second Affiliated Hospital of Jilin University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1080/07853890.2025.2578729
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00